Neil Iyengar, MD

Thanks to @AmericanCancer for reporting this important data showing a continued rise in cancer rates among young people, particularly young women. Check out our summary discussion on @GMA today. @MSKCancerCenter

An honor to receive funding for this work from @TheVFoundation for Cancer Research. We hope to be able to better understand how improving metabolic health through exercise or weight loss reduces the risk of cancer. Couldn’t ask for a better partnership!

What happens when you query chatGPT with 362 breast cancer cases? -46% responses differed from breast cancer expert opinion -when the same case was entered 3 times, the responses differed ~2/3 of the time ! -for examples, see 🧵..

“It is incredibly important for us, as a field, to be thinking about how our diet and lifestyle impacts not just our risk of developing [colon] cancer, but then how people fare after it,” @DanaFarber’s @SaraKCharMD told @CNN. Read more about promising new research presented at…

The breast cancer session at #DDHO2025 concludes with a patient-based panel discussion and Q&A—bringing together expert perspectives and patient-centered insights to close out a day of impactful dialogue.

Absolutely outstanding breast cancer session at #DDHO2025. Major themes included treatment de-escalation strategies, adjuvant advances making cure even more possible, and of course lifestyle guidance. I am so incredibly excited to join the remarkable team at @WinshipAtEmory

Winship breast medical oncologist and director of survivorship services, Neil M. Iyengar, MD, (@Neil_Iyengar) discusses optimizing survivorship—highlighting strategies to improve quality of life and long-term outcomes for cancer survivors at #DDHO2025.

Listening to @DrFadloKhuri deliver a phenomenal keynote. In an expansive review of cancer advances and future: “Dysregulation of metabolism unquestionably leads to cancer. We will see an era where we treat diabetes and cancer etiology together”. #DDHO2025 @WinshipAtEmory

Delighted to join on the 25th anniversary of this inspiring meeting showcasing the exciting progress in cancer treatment.

The Glenn Family Breast Cancer Center @WinshipAtEmory invites you to join the @OncLive State of the Science Summit on Breast Cancer. Tuesday, July 29, from 6:00-9:00 PM EST. The event features a dinner, networking reception, and prize raffle! Register: registration.onclive.com/soss-breast-at…

For those interested in this important topic, consider submitting to our special issue of JNCI Cancer Spectrum on #exercise, #nutrition, and #cancer outcomes! academic.oup.com/jncics/pages/c… @jamesbyu

How do #nutrition & #diet impact #CancerRisk & outcomes: from childhood to adulthood? Find out at the next @IARCWHO - ESMO webinar: “Nutrition, diet & cancer” 🗓️ 22 July 2025, 15:00–16:30 CEST 🔗 Register: ow.ly/EgT450Wnyvz #CancerPrevention #Oncology

We need nutritional screening in every cancer patient, even normal weight, through body composition & at molecular level. Patients' stratification can help us assess nutritional/metabolic risks of inflammatory implications in cancer #lipidomic @Nature_NPJ nature.com/articles/s4152…

Thank you @MSK_DeptOfMed ! I will always carry my @MSKCancerCenter experience with me and I look forward to continued collaborations with MSK’s amazing scientists and physicians, who I am fortunate to call friends.

I am delighted to join @WinshipAtEmory as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!

Lean body mass–based oxaliplatin dosing reduces peripheral neuropathy in stage III colon cancer without compromising survival! ✅ Lower rates of grade ≥2 oxaliplatin-induced peripheral neuropathy ✅ Better quality of life ✅ No impact on relapse-free survival or overall survival…

Dapiglutide is a first-in-class dual GLP1/GLP2 agonist. A hypothesis is GLP2 agonism can have a unique anti-inflammatory effect. Phase 1 Data presented at #ADA2025 today

New updates coming, but first- It’s hard to put into words what this group means to me - mentors, friends, family. I’ve leaned on them, laughed, cried, and grown with them. This isn’t goodbye, just deep gratitude for every moment we shared- and more to come. @MSKCancerCenter

Looking forward to important findings and conversations about environmental exposures (microplastics, chemicals/particles/endocrine disrupters), lifestyle (exercise, diet, stress) and more on cancer risk.

BMI analysis of ASCENT. Overweight/obese pts experienced higher rates of serious AEs (34% vs 18%) with SG and 41% of obese pts required dose reduction (vs 10%). Should we cap the dose of SG for overweight/obese pts, similar to other ADCs (eg EV, Dato-DXd)? esmoopen.com/action/consume…

I’ve been in the exercise oncology field for 20 years and for all of that time, the main criticism has been “show me a well controlled RCT.” Well, here it is. Exercise following adjuvant chemotherapy for colon cancer reduced recurrence and improves OVERALL SURVIVAL! #ASCO25…